Overview

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 Co-administered With Trimethobenzamide Hydrochloride in Healthy Subjects

Status:
Completed

Trial end date:
2014-12-01

Target enrollment:

Participant gender:

Summary

This study will test the hypothesis that PF-06649751 with continuous co-administration of trimethobenzamide hydrochloride (TMB) with will be safe and well tolerated. Single doses of PF-06649751 will be tested in this study, starting at a low dose and escalating to a dose projected to be under the current limits for drug concentration.

Phase:

Phase 1

Details

Lead Sponsor:

Pfizer

Treatments:

Trimethobenzamide